Diseases: Page 6

T2 Biosystems gets FDA nod to expand bacteria panel
By LabPulse.com staff writers
T2 Biosystems announced it received 510(k) clearance to add A. baumannii to its T2Bacteria Panel.
February 12, 2024
Fda Button Social
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
By LabPulse.com staff writers
CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect Neisseria gonorrhoeae, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.
February 8, 2024
Bacteria Neisseria Gonorrhoeae Social
High hopes for accurate blood test detecting malignant brain tumors
By Matt Limb
A simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.
February 9, 2024
Blood Test Samples Lab Social
U.K. trial for mRNA-based cancer therapy begins
By Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
Messenger Rna M Rna Social
NHS launches Jewish BRCA mutations testing program
By LabPulse.com staff writers
The U.K. National Health Service (NHS) is launching a national genetic testing program aimed at people in England with Jewish ancestry who may be carriers of mutations in BRCA1 and BRCA2 genes that increase their risk of certain cancers.
February 5, 2024
Dna Genome Gene Targeted Social
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
Antigen Tcell Cytokines Social
CRISPR-repaired T cells cure lethal hyperinflammation in mice
By Nick Paul Taylor
Memory T cells repaired using CRISPR-Cas9 can cure lethal hyperinflammation in mice, suggesting the approach may improve outcomes in a disease with a five-year probability of survival of around 50%.
February 2, 2024
T Cell Social
Hologic receives FDA clearance for digital cytology scanner platform in U.S.
By Liz Carey
Acknowledging human papillomavirus (HPV) as a causative agent for cervical cancer, the new system is designed to complement molecular testing for HPV with cotesting for cervical cancer.
February 2, 2024
Genius Review Station Social
DermTech to lay off 30 employees, take further restructuring measures
By LabPulse.com staff writers
DermTech will lay off 30 employees and take additional restructuring measures to cut operating expenses, streamline operations, and focus its resources on revenue growth.
February 1, 2024
Melanoma Social
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Lab Microscope Slide Social
Blood test for Alzheimer’s shows high accuracy in study
By Matt Limb
Scientists have hailed study results showing the high accuracy of a blood test that “could revolutionize” diagnosis of Alzheimer’s disease.
January 31, 2024
Alzheimers Tau Tangles Social
FDA orders new info warnings on CAR-T therapies
By LabPulse.com staff writers
Following its review of reports of T-cell malignancies associated with the administration of six CAR-T immunotherapies, the FDA has instructed the manufacturers to include warnings in the prescribing info for the therapeutics.
January 30, 2024
Fda Button Social
Previous Page
Page 6 of 284
Next Page